Who invested in Kynexis?
2 investors are on record as having backed Kynexis — Oral drug to improve cognition in brain diseases, in Biotech, Netherlands. Each row below says whether the round came from the investor's own portfolio page or from the press.
kynexistx.comKynexis investors
Sunstone CapitalInvests in early-stage life science companies developing novel therapeutics.their site
Ysios CapitalInvests in highly innovative biotech developing novel therapies for high unmet medical…their site
No round dates are on record for Kynexis. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Kynexis are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.